World Library  
Flag as Inappropriate
Email this Article

Barbiturate overdose

Article Id: WHEBN0026983645
Reproduction Date:

Title: Barbiturate overdose  
Author: World Heritage Encyclopedia
Language: English
Subject: Intoxicative inhalant, Alcoholic beverage, Ethanol, Judy Garland, Diacetylnalorphine
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Barbiturate overdose

Barbiturate overdose
Classification and external resources
ICD-10 F13.0, T42.3
ICD-9 969
eMedicine article/813155

A barbiturate overdose results when a person takes excessive doses of barbiturates. Symptoms of an overdose typically include sluggishness, incoordination, difficulty in thinking, slowness of speech, faulty judgment, drowsiness, shallow breathing, and staggering. In severe cases, coma and death can result.[1] The lethal dosage of barbiturates varies greatly with tolerance and from one individual to another.[2]

Barbiturate overdose with other CNS (central nervous system) depressants, such as alcohol, opiates or benzodiazepines, is even more dangerous due to additive CNS and respiratory depressant effects. In the case of benzodiazepines, barbiturates also increase the binding affinity of the benzodiazepine binding sites thus leading to an exaggerated effect of benzodiazepines.[3] This makes the predicting the effect of combinations difficult and the same dose of the same drugs will not always produce the same degree of sedation and respiratory depression as the previous experience.

Benzodiazepines increase the frequency of chloride channel opening while barbiturates increase the duration that the chloride pore remains open. If a normal pore opened once every 30 seconds to pass one chloride ion, a benzodiazepine may cause it to open once every ten seconds while a barbiturate may cause it to remain open until three ions have passed through. Separately, both of these increase the effect of the pore threefold, but together, the channel would allow three ions to pass every 10 seconds. This would exponentially increase the effect of the pore ninefold, greater than the sum of the two drugs effects.

The treatment of barbiturate abuse or overdose is generally supportive. The amount of support required depends on the person's symptoms. If the patient is drowsy but awake and can swallow and breathe without difficulty, the treatment can be as simple as monitoring the patient closely. If the patient is not breathing, it may involve mechanical ventilation until the drug has worn off.

Supportive treatment often includes the following:

  • Activated charcoal may be given via nasogastric tube.
  • Intubation and megamide, or a hand-breather where these are not available until the patient can breathe under their own power.
  • Observation in the Emergency Department for a number of hours or admission to the hospital for several days of observation if symptoms are severe.
  • Advise the patient about drug misuse or refer for psychiatric consult.

In famous cases, Marilyn Monroe, Dalida,[4][5] Judy Garland, Jimi Hendrix, and also Edie Sedgwick died from a barbiturate overdose.

See also

References

  1. ^ "Barbiturate intoxication and overdose". MedLine Plus. Retrieved 15 July 2008. 
  2. ^ Keltner, Norman (2010) Psychiatric Nursing 6th ed., Mosby, ISBN 0323069517.
  3. ^ Miller LG, Deutsch SI, Greenblatt DJ, Paul SM, Shader RI (1988). "Acute barbiturate administration increases benzodiazepine receptor binding in vivo". Psychopharmacology (Berl.) 96 (3): 385–90.  
  4. ^ "Dalida". New York Times. 5 May 1987. Retrieved 28 February 2008. 
  5. ^ Simmonds, Jeremy (2008). v.  
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.